These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18035732)

  • 1. [Problems of screening novel antituberculosis antibiotics. 3. New data on mechanism of action of antituberculosis agents].
    Bibikova MV; Borisova NA; Orekhov SN; Katlinskiĭ AV
    Antibiot Khimioter; 2006; 51(7):34-40. PubMed ID: 18035732
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems of screening of novel antituberculosis antibiotics. 1. Present notions of specific biological properties of human tuberculosis pathogen Mycobacterium tuberculosis].
    Bibikova MV; Borisova NA; Orekhov SN; Katlinskiĭ AV
    Antibiot Khimioter; 2006; 51(1):22-7. PubMed ID: 16734362
    [No Abstract]   [Full Text] [Related]  

  • 3. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis.
    Jackson M; McNeil MR; Brennan PJ
    Future Microbiol; 2013 Jul; 8(7):855-75. PubMed ID: 23841633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and bioactivity evaluation of Galf mimics as antitubercular agents.
    Liu C; Hou L; Meng A; Han G; Zhang W; Jiang S
    Carbohydr Res; 2016 Jun; 429():135-42. PubMed ID: 26706033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospects for design of novel antituberculosis drugs].
    Nikitin AV
    Antibiot Khimioter; 2006; 51(9-10):56-60. PubMed ID: 18030793
    [No Abstract]   [Full Text] [Related]  

  • 7. [New antitubercular antibiotics screening. 2. Characterisation of cell wall in Mycobacterium tuberculosos].
    Bibikova MV; Borisova NA; Orekhov SN; Katlinskiĭ AV
    Antibiot Khimioter; 2006; 51(6):23-6. PubMed ID: 17523418
    [No Abstract]   [Full Text] [Related]  

  • 8. ubiA (Rv3806c) encoding DPPR synthase involved in cell wall synthesis is associated with ethambutol resistance in Mycobacterium tuberculosis.
    He L; Wang X; Cui P; Jin J; Chen J; Zhang W; Zhang Y
    Tuberculosis (Edinb); 2015 Mar; 95(2):149-54. PubMed ID: 25547657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Vancomycin Susceptibility in Mycobacteria: a New Approach To Identify Synergistic Activity against Multidrug-Resistant Mycobacteria.
    Soetaert K; Rens C; Wang XM; De Bruyn J; Lanéelle MA; Laval F; Lemassu A; Daffé M; Bifani P; Fontaine V; Lefèvre P
    Antimicrob Agents Chemother; 2015 Aug; 59(8):5057-60. PubMed ID: 26033733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hixozide, a novel combined antituberculosis preparation].
    Glushkov RG; Sokolova GB
    Antibiot Khimioter; 2008; 53(5-6):11-3. PubMed ID: 19069176
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development.
    Bailo R; Bhatt A; Aínsa JA
    Biochem Pharmacol; 2015 Aug; 96(3):159-67. PubMed ID: 25986884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis.
    Lee AS; Othman SN; Ho YM; Wong SY
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4447-9. PubMed ID: 15504879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I3-Ag85 effect on phthiodiolone dimycocerosate synthesis.
    Rens C; Laval F; Wattiez R; Lefèvre P; Dufrasne F; Daffé M; Fontaine V
    Tuberculosis (Edinb); 2018 Jan; 108():93-95. PubMed ID: 29523333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of efflux pump genes of Mycobacterium tuberculosis in response to varied subinhibitory concentrations of antituberculosis agents.
    Garima K; Pathak R; Tandon R; Rathor N; Sinha R; Bose M; Varma-Basil M
    Tuberculosis (Edinb); 2015 Mar; 95(2):155-61. PubMed ID: 25680943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
    Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
    Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in genes associated with drug resistance in Mycobacterium tuberculosis isolates from Italy.
    Musser JM; Amin A; Ramaswamy S
    J Infect Dis; 1999 Nov; 180(5):1751-3. PubMed ID: 10515850
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and biological evaluation of trehalose analogs as potential inhibitors of mycobacterial cell wall biosynthesis.
    Rose JD; Maddry JA; Comber RN; Suling WJ; Wilson LN; Reynolds RC
    Carbohydr Res; 2002 Feb; 337(2):105-20. PubMed ID: 11814442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs and drug targets against tuberculosis.
    Lambert N; Abdalla AE; Duan X; Xie J
    J Drug Target; 2017 Apr; 25(4):296-306. PubMed ID: 27822967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postantibiotic effects of antituberculosis agents alone and in combination.
    Chan CY; Au-Yeang C; Yew WW; Hui M; Cheng AF
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3631-4. PubMed ID: 11709357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid detection of multidrug-resistant Mycobacterium tuberculosis by multiplex allele-specific polymerase chain reaction.
    Imperiale BR; Cataldi AA; Morcillo NS
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):496-501. PubMed ID: 21396209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.